ILAR Reclassification Study

ILAR Reclassification Study

Contact

 If you are interested in participating in the study or want to learn more, please contact: Contact us
This study is no longer recruiting.

Description
This study hopes to revise the currently used criteria for diagnoses of Juvenile Idiopathic Arthritis (JIA). This study aims to follow children newly diagnosed with JIA for up to five years. We will ask for a small blood sample for the first two visits, and for participants to fill out a back assessment. We will also record disease information from your medical record.

Eligibility and criteria
IRB Number:
19-016267
Clinical trial phase:
N/A
Official title:
The PRINTO Evidence-based Revision of the International League Against Rheumatism (ILAR) Classification criteria for juvenile idiopathic Arthritis.
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.